Clinical Trial Update: L-carnitine for Fatigue in COPD [Phase 2, Phase 3]

View source ↗

Summary

This document reports that a Phase 2/Phase 3 trial evaluating L-carnitine for fatigue in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• L-carnitine (L-carnitine)

Snippet

Sponsor: Mayo Clinic | Conditions: Copd, Fatigue | Phase 2, Phase 3 | Status: COMPLETED